semaglutide mc4r obesity real‑world data
Semaglutide Cuts 8% BMI in MC4R Deficiency, A Game-Changer
Semaglutide reduces BMI by up to 8% in patients with MC4R deficiency, and real-world studies confirm the effect can be reproduced in everyday practice. The drug’s impact goes beyond weight, improving hypertension and lipid profiles within months. In a 24-month retrospective cohort of 1,500 MC4R-deficient adults, daily oral